We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$14.7B
AUM Growth
+$562M
Cap. Flow
-$182M
Cap. Flow %
-1.24%
Top 10 Hldgs %
20.54%
Holding
1,679
New
173
Increased
492
Reduced
677
Closed
92

Top Buys

Rank Stock Value
1
P
Everpure Inc
P
+$58.5M
2
DOCU
DocuSign
DOCU
+$21.3M
3
BKE icon
Buckle
BKE
+$20.9M
4
MSFT icon
Microsoft
MSFT
+$18.4M
5
USFD icon
US Foods
USFD
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 20.16%
2 Healthcare 17.99%
3 Financials 13.41%
4 Industrials 9.72%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZTA icon
976
Azenta
AZTA
$1.4B
$452K ﹤0.01%
13,854
+495
+4% +$14.7K
CVSA
977
Covista Inc
CVSA
$4.43B
$450K ﹤0.01%
9,348
-123
-1% -$5.88K
CHX
978
DELISTED
ChampionX
CHX
$450K ﹤0.01%
+10,782
New +$441K
VSS icon
979
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
$450K ﹤0.01%
3,897
+568
+17% +$68K
VIAV icon
980
Viavi Solutions
VIAV
$9.83B
$449K ﹤0.01%
43,836
+5,775
+15% +$57.1K
BY icon
981
Byline Bancorp
BY
$1.79B
$447K ﹤0.01%
20,000
XLRE icon
982
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.57B
$447K ﹤0.01%
13,669
-2,419
-15% -$75.7K
TDY icon
983
Teledyne Technologies
TDY
$31.7B
$440K ﹤0.01%
2,208
-316
-13% -$62.4K
NTLA icon
984
Intellia Therapeutics
NTLA
$1.55B
$438K ﹤0.01%
+16,000
New +$388K
LUV icon
985
Southwest Airlines
LUV
$24.1B
$436K ﹤0.01%
8,569
-230
-3% -$12.1K
VVC
986
DELISTED
Vectren Corporation
VVC
$436K ﹤0.01%
6,102
NDAQ icon
987
Nasdaq
NDAQ
$52.8B
$435K ﹤0.01%
14,301
PNR icon
988
Pentair
PNR
$11B
$435K ﹤0.01%
10,339
-2,425
-19% -$109K
ELV icon
989
Elevance Health
ELV
$84.2B
$430K ﹤0.01%
1,805
-326
-15% -$75.5K
SCHF icon
990
Schwab International Equity ETF
SCHF
$68.4B
$429K ﹤0.01%
25,954
+28
+0.1% +$476
LMRK
991
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$427K ﹤0.01%
30,824
-3
-0% -$44
WFT
992
DELISTED
Weatherford International plc
WFT
$426K ﹤0.01%
129,516
+2,500
+2% +$7.79K
PRMW
993
DELISTED
Primo Water Corporation
PRMW
$426K ﹤0.01%
+24,375
New +$362K
IYJ icon
994
iShares US Industrials ETF
IYJ
$2.04B
$425K ﹤0.01%
5,914
UAL icon
995
United Airlines
UAL
$43.4B
$425K ﹤0.01%
6,100
-54
-0.9% -$3.75K
VCR icon
996
Vanguard Consumer Discretionary ETF
VCR
$6.31B
$425K ﹤0.01%
2,505
+237
+10% +$39.2K
CORT icon
997
Corcept Therapeutics
CORT
$11.9B
$424K ﹤0.01%
27,000
OLED icon
998
Universal Display
OLED
$3.91B
$420K ﹤0.01%
4,880
+300
+7% +$28.6K
GRFS
999
Grifois
GRFS
$5.39B
$419K ﹤0.01%
19,492
-19,468
-50% -$425K
TBT icon
1000
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$310M
$419K ﹤0.01%
11,668
+50
+0.4% +$1.87K

Similar funds

William Blair & Company's Q2 2018 Portfolio in Review

As of Q2 2018, William Blair & Company held 1,679 positions worth $14.7B, up 4% from $14.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

William Blair & Company's Q2 2018 filing shows 173 new, 492 increased, 677 reduced and 92 closed positions. Its largest new stake was DocuSign: 422,114 shares worth $22.4M. The largest sale was Starbucks, an estimated $47M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q2 2018 buy was DocuSign: 422,114 shares worth $22.4M.
  • William Blair & Company added most to Everpure Inc in Q2 2018, an estimated $58.5M increase.
  • William Blair & Company's biggest Q2 2018 reduction was Starbucks, cutting an estimated $47M.
  • William Blair & Company fully exited Cavium, Inc. in Q2 2018, selling an estimated $9.64M.
  • William Blair & Company's ten largest holdings make up 21% of its $14.7B portfolio in Q2 2018.
  • William Blair & Company opened 173 new positions and closed 92 in Q2 2018.
  • William Blair & Company's portfolio value rose 4% quarter-over-quarter to $14.7B.

Based on William Blair & Company's 13F filing for Q2 2018, filed 13 Aug 2018.